10 Biotech Stocks to Buy Today According to Ken Fisher
In this piece, we will take a look at the ten biotechnology stocks to buy according to Ken Fisher's Fisher Asset Management.
West Pharmaceutical Services Inc (WST)
Market is closed
Sector: Fabricated Rubber Products, Nec
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Durable Capital Partners Henry Ellenbogen | 748,331 | $307,347 | -13% | 2.69% |
| 2. | Citadel Investment Group Ken Griffin | 395,131 | $162,284 | +38791% | 0.03% |
| 3. | Fisher Asset Management Ken Fisher | 264,877 | $108,788 | -2% | 0.06% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 256,693 | $105,426 | -50% | 0.13% |
| 5. | Intermede Investment Partners Barry Dargan | 244,804 | $100,543 | +8% | 2.35% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $105.14 | 54 | 66,251 | 2019-02-28 | Filing | ||
| $110.55 | 57 | 66,197 | 2018-07-31 | Filing | ||
| $93.94 | 335 | 66,475 | 2017-10-17 | Filing | ||
| $88.89 | 275 | 56,540 | 2018-05-15 | Filing | ||
| $84.53 | 332 | 51,831 | 2016-12-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $374.92 | 200 | 5,372 | 2022-03-14 | Filing | ||
| $374.45 | 2,940 | 5,572 | 2022-03-14 | Filing | ||
| $372.92 | 900 | 8,512 | 2022-03-14 | Filing | ||
| $371.89 | 600 | 9,412 | 2022-03-14 | Filing | ||
| $370.94 | 446 | 10,012 | 2022-03-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 559,074 | $229,617,283 | 0.09% | |
| 2. | 40,032 | $16,441,542 | 0.13% | |
| 3. | 30,879 | $12,682,314 | 0.01% | |
| 4. | 25,272 | $10,379,464 | 0.13% | |
| 5. | 14,499 | $5,954,884 | 0.03% |
News See All
Is it "Take Profit" Season for West Pharmaceutical (WST)?
Baron Funds, an asset management firm, published its “Baron Asset Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.
Hedge Funds Are Souring On West Pharmaceutical Services Inc. (WST)
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Baron Funds: "West (WST) has a Long Runway for Growth"
Baron Funds, an asset management firm, published its “Baron Asset Fund” third quarter 2021 investor letter – a copy of which can be downloaded here.
Where Do Hedge Funds Stand On West Pharmaceutical Services Inc. (WST)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Here's Why Artisan Partners Trimmed its West Pharmaceutical Services (WST) Position
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Mid Cap Fund’ second quarter 2021 investor letter – a copy of which can be downloaded here.
Baron Funds: "We Expect TransUnion (TRU) to Continue Gaining Market Share in its Core Market"
Baron Funds, an asset management firm, published its “Baron Asset Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
"West Pharmaceutical (WST)'s Core Business Performed Exceptionally Well", According to Baron Funds
Baron Funds, an asset management firm, published its “Baron Health Care Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
5 Pharma Companies Making Treatment for Opioid Overdose
In this article, we discuss the 5 pharma companies making treatment for opioid overdose.
Do Hedge Funds Love West Pharmaceutical Services Inc. (WST)?
In this article we will take a look at whether hedge funds think West Pharmaceutical Services Inc. (NYSE:WST) is a good investment right now.
Billionaire Hedge Funds
